2 news items
U.S. Medicines Spending Grew in 2023 as Greater Access Offset COVID-19-related Decline, Says IQVIA Institute
IQV
14 May 24
indicators except for new prescriptions, which were up 4%. New prescriptions for chronic and acute conditions were both above pre-pandemic levels in 2023
IQVIA Reports First-Quarter 2024 Results
IQV
2 May 24
to a number of factors, including, but not limited to, the following: business disruptions caused by natural disasters, pandemics such as the COVID-19
- Prev
- 1
- Next